vimarsana.com
Home
Live Updates
Novel Drug Shows a Signal to Improve nHCM : comparemela.com
Novel Drug Shows a Signal to Improve nHCM
In the phase 2 IMPROVE-HCM trial, cardiac mitotrope ninerafaxstat was safe, with a signal of improved cardiac function in moderate nonobstructive hypertrophic cardiomyopathy.
Related Keywords
Massachusetts ,
United States ,
University Of Pennsylvania ,
Pennsylvania ,
Burlington ,
Philadelphia ,
Martins Maron ,
Himabindu Vidula ,
Journal Of The American College Cardiology ,
Hypertrophic Cardiomyopathy Center At Lahey Medical ,
American College Of Cardiology ,
American College ,
Greatest Unmet ,
Hypertrophic Cardiomyopathy Center ,
Lahey Medical Center ,
Cardiomyopathy ,
Exercise ,
Physical Activity ,
Hypertrophic Cardiomyopathy ,
Heart Failure ,
Heart ,
Metabolism ,
Etabolic ,
Fatty Acids ,
Kansas ,
Ventilator ,
Medical Ventilator ,
Mechanical Ventilation ,
comparemela.com © 2020. All Rights Reserved.